OrganoTherapeutics is a spin-off project from the University of Luxembourg. We use innovative human mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease. We screen for novel compounds which can be therapeutic for different patient groups.

MIDBRAIN ORGANOIDS
Organoids contain high amount of dopaminergic neurons but also other type of neurons (GABAergic, glutamatergic) and astrocytes.

About our model

FURTHER DEVELOPMENT
They can be enriched with endothelial cells and microglia.

PHENOTYPING AND DRUG DISCOVERY
Midbrain organoids from PD patients show dopaminergic neuron impairment. We are specialized in compound screening and drug discovery.